Floatz logo

Desflurane

Colorectal Cancer

Peter MacCallum Cancer Centre, AustraliaSmall moleculePhase 4 / ApprovedDormant
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

840 Active assets in the Colorectal Cancer cohort.

Asset / SponsorPhaseRating
MARBLE DUST
James Varani
Phase 2/3BB
Orectalip
Sinphar Pharmaceutical Co., Ltd
Phase 4BB
Eloxatin
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 4BB
PANITUMUMAB
MSPU des 3 Provinces
Phase 3BB
FENTANYL
Mansoura University
Phase 4BB

View all 50 →

Same molecule, other indications

Desflurane is also rated in:

Circulating Tumor CellsDormant
BBB
Indicative ·
74 / 100
View asset →
Anesthesia, LocalDormant
BBB
Indicative ·
73 / 100
View asset →
prostate cancerDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →